United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares of Stock

United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares of Stock

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the stock in a transaction that occurred on Monday, March 30th. The stock was sold at an average price of $590.59, for a total transaction of $5,610,605.00. Following the transaction, the chief executive officer directly owned 40,513 shares of the company’s stock, valued at $23,926,572.67. The trade was a 19.00% decrease in their position. …

Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,610,605.00 in Stock

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the business’s stock in a transaction that occurred on Monday, March 30th. The stock was sold at an average price of $590.59, for a total value of $5,610,605.00. Following the transaction, the chief executive officer owned 40,513 shares of the […]